Given the range of potential clinical trial disruptions due to COVID-19, Cytel’s experienced team of statisticians and data scientists can work with you to identify any potential challenges and complications you may be facing. Our team of experts can support you by providing a range of solutions to overcome your toughest challenges and get your trial back on track
Cytel software helps you deliver the impossible
You’ve been asked to conduct research at an unprecedented rate – to deliver the impossible. Cytel’s software portfolio gives you adaptive, Bayesian, and exact tools to go fast and learn.
Design Faster, Smarter COVID-19 Trials: manage uncertainty, improve efficiency, and increase the likelihood of technical success with East.
Accurately Analyze Imperfect COVID-19 Data: Rethink how you leverage data to draw conclusions with the Xact portfolio.
Accelerate Defensible Decisions for Faster COVID-19 Development: Cytel’s OKGO helps you move faster and smarter with a Bayesian framework for structuring decisions in advance.
As the race to find a solution to the coronavirus pandemic intensifies a team of data scientists can become important partners on the journey.
Quickly and Confidently Address COVID-19 Disruptions
You had a strong plan, but the COVID-19 outbreak is disrupting trials globally. Get your enrollment forecast and data analysis plan back on track with EnForeSys and StatXact.